FDA Accepts COVID-19 Clinical Study and Advises on Next Steps for Pre-IND Filing by Medolife Rx
June 23, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., June 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer...
Medolife Rx Launches National TV PSA Campaign Promoting Escozine and Activates Customer Service Center
June 01, 2021 08:00 ET
|
Quanta, Inc.
BURBANK, Calif., June 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Completes Initial Meeting with Bioethics Committee, Preparing for Commencement of Phase II Clinical Trial on Lead Drug Candidate
May 20, 2021 08:00 ET
|
Quanta, Inc.
BURBANK, Calif., May 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Announces Changes in Management, Puts New Executive Leadership in Place
May 11, 2021 08:00 ET
|
Quanta, Inc.
BURBANK, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Implements Proprietary Electro Solution, Further Increasing Efficacy of Polarization Technology
May 06, 2021 08:00 ET
|
Quanta, Inc.
BURBANK, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx to Present at The 2021 Sequire Cannabis Conference on Tuesday, April 20, at 3 p.m. EST/12 p.m. PST
April 15, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Submits Final Data Set to FDA for IND Filing on Lead Drug Candidate
April 13, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Announces Positive Pre-Clinical Results Showing Up to 95 Percent Cancer Cell Apoptosis with Introduction of Lead Cancer Drug Candidate
April 08, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Furthers Expansion of Scorpion Reservation; Prepares for Mass Production of Escozine Required Upon Product Registration
March 30, 2021 09:00 ET
|
Quanta, Inc.
BURBANK, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...
Medolife Rx Announces Positive Results in Clinical Safety Study on Its Polarized Drug Candidate for the Treatment of COVID-19
March 18, 2021 08:30 ET
|
Quanta, Inc.
BURBANK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product...